Microba Life Sciences (ASX:MAP) FCF Yield % : -27.25 (As of May. 25, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Microba Life Sciences FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Microba Life Sciences's Trailing 12-Month Free Cash Flow is A$-23.19 Mil, and Market Cap is A$85.09 Mil. Therefore, Microba Life Sciences's FCF Yield % for today is -27.25%.

The historical rank and industry rank for Microba Life Sciences's FCF Yield % or its related term are showing as below:

ASX:MAP' s FCF Yield % Range Over the Past 10 Years
Min: -32.36 Med: 0 Max: 0
Current: -27.25

ASX:MAP's FCF Yield % is ranked worse than
73.71% of 232 companies
in the Medical Diagnostics & Research industry
Industry Median: -3.815 vs ASX:MAP: -27.25

Microba Life Sciences's FCF Margin % for the quarter that ended in Dec. 2023 was -406.17%.

Microba Life Sciences FCF Yield % Historical Data

The historical data trend for Microba Life Sciences's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microba Life Sciences FCF Yield % Chart

Microba Life Sciences Annual Data

Trend

Jun22

Jun23

FCF Yield %

-21.19

-14.11

Microba Life Sciences Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	-	-	-9.23	-18.09	-32.98

Competitive Comparison of Microba Life Sciences's FCF Yield %

For the Diagnostics & Research subindustry, Microba Life Sciences's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Microba Life Sciences's FCF Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Microba Life Sciences's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Microba Life Sciences's FCF Yield % falls into.

Microba Life Sciences FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Microba Life Sciences's FCF Yield % for the fiscal year that ended in Jun. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-15.431	/	109.3944
	=	-14.11%

Microba Life Sciences's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-13.294	*	2	/	80.61336
	=	-32.98%

Microba Life Sciences FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Microba Life Sciences FCF Yield % Related Terms

Thank you for viewing the detailed overview of Microba Life Sciences's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Microba Life Sciences (ASX:MAP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Microba Life Sciences Ltd (ASX:MAP) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000

Website

https://www.microba.com

Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome which includes delivering gut microbiome testing services globally to consumers, clinicians, and researchers. The company's segment includes Testing Services, and Research and Development.

Microba Life Sciences (ASX:MAP) Headlines

No Headlines